Vimarsana
Biggest News Aggregation in the World

Serum Igg News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Serum Igg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Serum Igg Today - Breaking & Trending Today

New ICD-10 Code is An Important Milestone for Rare Disease Patients - Vimarsana News

New ICD-10 Code is An Important Milestone for Rare Disease Patients

The introduction of an ICD-10 code specific to IgG4-Related Disease offers a promising opportunity to revolutionize patient care, enable more accurate diagnoses, and improve outcomes.

Cureus | A Case Report of a Prevertebral Mass in an Elderly Male Post Hodgkin's Lymphoma - Vimarsana News

Cureus | A Case Report of a Prevertebral Mass in an Elderly Male Post Hodgkin's Lymphoma

Immunoglobulin G4-related disease (IgG4-RD) is a fibroinflammatory autoimmune disease characterized by tissue infiltration by dense lymphoplasmacytic infiltrate composed of T cells, activated B-cells, and plasma cells expressing IgG4 and has varied presentations with similar histopathology. It can involve visceral organs, glands, aorta, lymph nodes, and retroperitoneal tissue. In our case, a 68-year-old male with a past history of Hodgkin's lymphoma and in remission presented for investigation of polyclonal gammopathy. Serum electrophoresis showed increased free kappa light chains, free l...

Source: cureus.com
Clinical characteristics of 37 Cases IgG4-Related Disease - Vimarsana News

Clinical characteristics of 37 Cases IgG4-Related Disease

Analyzing the clinical characteristics of patients tested for serum IgG4 because of suspecting IgG4-RD for a better understanding of the specific disorder.

Animal study suggests intranasal COVID vaccine delivery more efficient than intramuscular - Vimarsana News

Animal study suggests intranasal COVID vaccine delivery more efficient than intramuscular

In a recent study published in the journal PNAS, researchers demonstrated higher comparative efficacy of the intranasal (IN) route of coronavirus disease 2019 (COVID-19) vaccine administration versus intramuscular route in mice.

Early B cell signatures predict antibody responses to mRNA-based COVID-19 vaccine - Vimarsana News

Early B cell signatures predict antibody responses to mRNA-based COVID-19 vaccine

Early B cell signatures predict antibody responses to mRNA-based COVID-19 vaccine Researchers in the United States have identified both antigen-specific and antigen non-specific predictive signatures of antibody responses to Moderna’s two-dose coronavirus disease 2019 (COVID-19) vaccine that protects against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The team found that after both vaccine doses, robust and coordinated immunoglobulin A (IgA) and IgG responses were preceded by bursts of plasmablasts that are specific to the SARS-CoV-2 spike protein, although ...